Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway

To test whether transmembrane (TMEM) 9A protein might promote breast cancer progression, researchers performed a series of loss/gain-of-function experiments and found that breast cancer cells with TMEM9A deletion inhibited cell proliferation, migration, and invasion along with induced apoptosis.